tiprankstipranks
Valeo Pharma (VPHIF)
OTHER OTC:VPHIF
US Market
VPHIF
Valeo Pharma
RESEARCH TOOLSreports
Want to see VPHIF full AI Analyst Report?

Valeo Pharma (VPHIF) Income Statement

14 Followers

Valeo Pharma Income Statement

Last quarter (Q3 2024), Valeo Pharma's total revenue was C$12.60M, a decrease of -10.52% from the same quarter last year. In Q3, Valeo Pharma's net income was C$-8.19M. See Valeo Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Oct 23Oct 22Jan 22Jan 21Jan 20
Total Revenue
C$ 53.91MC$ 27.75MC$ 13.56MC$ 7.47MC$ 6.58M
Gross Profit
C$ 13.08MC$ 6.28MC$ 3.96MC$ 1.38MC$ 1.40M
Operating Expenses
C$ 30.30MC$ 28.12MC$ 16.65MC$ 5.72MC$ 5.14M
Depreciation and Amortization
C$ 2.63MC$ 1.05MC$ 407.00KC$ 424.00KC$ 135.00K
EBITDA
C$ -11.39MC$ -16.10MC$ -10.97MC$ -3.74MC$ -3.41M
Operating Income
C$ -17.23MC$ -19.60MC$ -12.82MC$ -4.34MC$ -3.54M
Other Income/Expenses
C$ -10.58MC$ -7.32MC$ -1.42MC$ -418.00KC$ 122.00K
Pretax Income
C$ -27.81MC$ -26.92MC$ -14.23MC$ -4.76MC$ -3.62M
Net Income
C$ -27.81MC$ -25.75MC$ -14.23MC$ -4.76MC$ -3.62M
Per Share Metrics
Basic EPS
C$ -0.32C$ -0.32C$ -0.20C$ -0.08C$ -0.07
Diluted EPS
C$ -0.32C$ -0.32C$ -0.20C$ -0.08C$ -0.07
Weighted Average Shares Outstanding
 86.12M 80.86M 69.93M 57.91M 49.59M
Weighted Average Shares Outstanding (Diluted)
 86.12M 80.86M 69.93M 57.91M 49.59M
Currency in CAD

Valeo Pharma Earnings and Revenue History